The inferior turbinate: an autonomic organ by Smith, Drew Hayes
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2016
The inferior turbinate: an
autonomic organ
https://hdl.handle.net/2144/19467
Boston University
   
BOSTON UNIVERSITY  SCHOOL OF MEDICINE      Thesis      THE INFERIOR TURBINATE: AN AUTONOMIC ORGAN     by     DREW HAYES SMITH  B.S., Brigham Young University, 2015         Submitted in partial fulfillment of the  requirements for the degree of  Master of Science  2016  
   
 
 
 
 
                                 © 2016 by  DREW HAYES SMITH  All rights reserved  
   
Approved by  
 
 
 
First Reader    Michael P. Platt, M.D., M.Sc.  Associate Professor     Residency Director    Department of Otolaryngology-Head and Neck Surgery      
 
Second Reader    Christopher Brook, M.D.   Rhinology and Skull Base Surgery Fellow  Harvard University  
 
  
  iv
DEDICATION 
 
 
 
 
I would like to dedicate this work to my wife, Emily, and my son, Clint, for their constant 
love and support; and to my parents, Brandon and Megan, for always believing in me. 
 
 
  v
ACKNOWLEDGMENTS 
I would like to express my appreciation to my readers, Dr. Platt and Dr. Brook, for 
their guidance and insight while writing this thesis. Despite immensely full plates, 
they provided me with much more time and assistance than I hoped for. In addition, 
their quick responses and mentorship were especially appreciated. Thank you.  
I would also like to thank Taylor James Rasmussen, PharmD, who expertly drew 
figures 1-4 and 6-11.  
  
  vi
 
THE INFERIOR TURBINATE: AN AUTONOMIC ORGAN 
DREW HAYES SMITH 
ABSTRACT 
The inferior turbinates are important anatomical nasal structures that provide warmth, 
humidification, and filtration of the inspired air to provide optimal conditioning for lung 
function. Besides these well-established basic functions, the turbinates are also important 
in immune function as the interface between the airway and the environment. Proper 
functioning of the inferior turbinates relies on an intact autonomic system, which 
maintains homeostasis within the nasal cavity. The autonomic nervous system innervates 
the submucosal glands and the vasculature within the inferior turbinate, resulting in 
control of major turbinate functions: nasal secretions, nasal patency, and amount of 
warmth and humidification provided. This thesis will summarize the normal and 
abnormal autonomic processes that contribute to the inferior turbinate as an autonomic 
organ. 
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INTRODUCTION 
In the first part of this thesis, the anatomy of the inferior turbinate will be described, 
including its histology, embryology, blood supply, innervation, and autonomic receptors. 
Next, normal physiological function of the inferior turbinate under autonomic control will 
be explained, including nasal patency and the nasal cycle, airway resistance, secretion, 
and immunity. Environmental changes that occur due to temperature, humidity, exercise, 
sleep, taste, and the crutch phenomenon will also be detailed. After this, turbinate 
pathology will be reviewed, including structural abnormalities, infectious disease, allergic 
rhinitis, sleep apnea, empty nose syndrome, and local drug impacts as well as side effects 
from other autonomic medicines. Finally, methods of reduction will be described, 
including medical and surgical.  
In the following introduction, background information regarding the basic anatomy and 
physiology of the nasal cavity will be explored, including its combined role with the 
lungs in respiration. Background information detailing the autonomic nervous system, 
including its anatomical origins and physiological functions in the human body, will also 
be examined.  
The Nasal Cavity 
The nose is an organ on the anterior section of the head that includes both an external 
portion and an internal portion. Externally, the nose is pyramidal in shape and is 
supported by bone and cartilage. The soft tissue is made up of skin, fibroadipose tissue, 
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and muscles that are mostly located around the nostrils and are controlled by the facial 
nerve. Internally, the nose consists of two nasal cavities on both sides of the dividing 
nasal septum as well as paranasal sinuses. The nasal cavities (Figure 1) are the proximal 
portion of the respiratory passages. They extend from the base of the skull to the superior 
roof of the mouth and continue from the face through the nostrils (anterior nares) to the 
opening of the superior part of the pharynx (throat), which is known as the nasopharynx. 
These cavities are lined with nasal mucosa, which is ciliated. The roof of the cavities, 
known as the olfactory cleft, is marked by a horizontal bone called the cribriform plate of 
the ethmoid bone. The cribriform plate is perforated with small holes that allow nerve 
endings to directly contact the outer surface mucosal membrane. This allows the sense of 
smell to function. The floor of the cavities sits on the hard palate above the mouth. The 
medial wall, known as the septum, separates the two cavities and is frequently deviated in 
adults, possibly because of ossification of the cartilaginous septum that occurs from the 
first year of life through the mid-thirties (Gizurarson 2012). 
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   Figure 1. Nasal Cavity. A sagittal section of the nasal cavity demonstrating its lateral wall.  
The lateral wall of the nasal cavities consists of superior, middle, and inferior folds 
known as turbinates or concha. These three folds (and occasionally a fourth, supreme 
conchae) produce three small passages within their folds called superior, middle and 
inferior meatuses (Figure 2). The purpose of these turbinates is to increase resistance to 
the airflow, thereby producing close contact between inspired air and the mucosal 
surface. The folded structure also greatly expands the surface area of the nasal cavity 
(Gizurarson 2012).  
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   Figure 2. Turbinates. A horizontal section through the main nasal passage demonstrating the turbinates.    Respiration 
The main goal of respiration, or breathing, is to exchanges gasses; oxygen from the 
atmosphere into the blood and carbon dioxide from the blood into the atmosphere. 
Respiration is driven by pressure changes in the lungs and thoracic cavity compared with 
the atmosphere (Figure 3).  
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Figure 3. Pressure Changes in the Lung. Air follows the pressure gradients created by inspiratory and expiratory muscles. Pressures, taken from (West 2008), are measured in cm H2O. A) Before inspiration, the pressures in the atmosphere and in the alveoli within the lungs are equal, and breathing momentarily pauses. B) Inspiration begins when the diaphragm muscle below the lungs contracts and moves inferiorly while external intercostal muscles in the chest wall contract to move the ribs superiorly and anteriorly, creating more space in the thoracic cavity for the lungs to expand. The expansion of the lungs decreases the pressure in the alveoli relative to the atmospheric pressure and air enters the lungs. C) Inspiration ends when the alveolar pressure equals the atmospheric pressure again. D) The diaphragm muscle then relaxes back into the thoracic cavity, increasing the relative pressure on the alveoli, forcing air back down the new concentration gradient, this time from the lungs to the nose and mouth until the pressures equalize. The cycle repeats itself.  
Air travels down its concentration gradient from the nose and mouth into the pharynx, 
larynx, trachea, and lungs (Figure 4). Oxygen in the air is taken up by hemoglobin in the 
blood through capillaries in the alveoli while carbon dioxide is released and exhaled 
through a similar mechanism. Through this, the body gets needed oxygen to its tissues 
while ridding itself of unwanted carbon dioxide (Garcia-Diaz 2016).  
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  Figure 4. Human Airways. The path of airflow from the atmosphere to the lungs and vice-versa.   
The Autonomic System 
The human nervous system is organized into two divisions (Figure 5), the central 
nervous system and the peripheral nervous system. The central nervous system includes 
the brain and spinal cord. The peripheral nervous system includes the somatic division 
and the visceral or autonomic division. The somatic nervous system consists of nerves 
that carry sensations from the periphery (sensory neurons) back to the central nervous 
system as well as nerves from that central nervous system that innervate voluntary 
muscles (motor neurons). The autonomic or visceral nervous system also has sensory and 
motor neurons, but is more involuntary. The sensory nerves monitor changes in the 
internal organs, while the motor nerves innervate involuntary smooth and cardiac muscle 
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as well as glands. The autonomic motor division is subdivided into sympathetic and 
parasympathetic sections, which tend to act reciprocally to each other (Drake, Vogl, and 
Mitchell 2012).  
    
  Figure 5. Nervous System Organization. The nervous system contains two main divisions, the central and peripheral nervous systems. Each division has subsets, as shown here.   
Anatomically, the sympathetic nervous system consists of preganglionic neurons or 
fibers, ganglions, and postganglionic neurons. Preganglionic fibers exit the spinal cord at 
the level at which their cell bodies are located, between T1 and L2. Most of the ganglia 
lie close to the spinal cord and form the sympathetic trunk (one on each side of the spinal 
cord).  Once in the trunk, preganglionic fibers travel upward or downward for several 
segments before forming synapses with many postganglionic neurons. The sympathetic 
system innervates structures in peripheral regions of the body as well as visceral organs 
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(Drake, Vogl, and Mitchell 2012). Sympathetic effects are generally referred to as a 
“fight or flight” response, so called for the need to mobilize energy, and the body in 
general, rapidly. Effects include an increase in heart rate and contraction, glycogenolysis, 
lipolysis, bronchial dilation, sweating, and skeletal muscle blood flow. There is a general 
decrease in gastrointestinal motility (“Autonomic Nervous System” 2016).  
The parasympathetic nervous system follows the same anatomical pattern of 
preganglionic neurons, ganglions, and postganglionic neurons, but differs in axon length. 
Preganglionic neurons have much longer axons because parasympathetic ganglia lie close 
to or are actually embedded in visceral target organs. Their preganglionic fibers also have 
a different exit location, leaving the spinal cord between C1 to C8 and L3 to S5, basically 
on either side of the sympathetic nerves. The parasympathetic system innervates the 
visceral organs only (Drake, Vogl, and Mitchell 2012). Parasympathetic effects are 
referred to as a “rest or digest” response because this state occurs at times when the body 
is conserving and storing energy. Effects include a decrease in heart rate, heart 
contractility, and blood flow to skeletal muscles. There is an increase in insulin secretion 
and blood flow to the gastrointestinal tract (“Autonomic Nervous System” 2016).  
The nervous system relays information between the brain and the body thru chemical 
messengers called neurotransmitters that travel along the neurons. The autonomic 
nervous system mainly relies on two neurotransmitters, acetylcholine and norepinephrine. 
Acetylcholine is used in preganglionic neurons of both the sympathetic and 
parasympathetic divisions as well as the postganglionic neurons of the parasympathetic 
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division. Norepinephrine is used in postganglionic neurons of the sympathetic division. 
Neurotransmitter receptors that recognize norepinephrine or epinephrine are termed 
adrenergic, while those that recognize acetylcholine are termed cholinergic. Cholinergic 
receptors can be further classified as nicotinic or muscarinic (“Neurotransmitters” 2016).  
In the following thesis, the inferior turbinate of the nasal cavity will be explored and its 
autonomic characteristics will be exhibited.  
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Specific Aims  
Specific aims of the following thesis include:  
1. Demonstrate autonomic properties that contribute to the function of the inferior 
turbinates, including both parasympathetic and sympathetic effects. 
2. Comprehensive review of the literature to characterize the anatomy, physiology, 
pathology, and methods of reduction of the inferior turbinates, as related to the 
autonomic nervous system. 
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ANATOMY OF THE INFERIOR TURBINATE  
Those who study anatomy are familiar with the phrase “form follows function.” The 
inferior turbinate is no different; its structural form is intricately linked to its 
physiological function. Both the inferior turbinate and the inferior meatus are the largest 
of the group and reach along the entire length of the lateral nasal wall. On the superior 
recess of the inferior meatus and lateral to the body of the inferior turbinate (Figure 6), 
there is an opening, known as Hassner’s valve, for the nasolacrimal duct that allows tears 
from the eye to exit through the nasal cavity (Gizurarson 2012). The inferior turbinate is 
made up of a bony frame underneath soft tissue, specifically respiratory epithelium. The 
bone itself is cancellous, consisting of interwoven trabeculae that accommodates the 
major arterial supply of the turbinate (Sahin-Yilmaz and Naclerio 2011).The inferior 
turbinate is also the only turbinate that develops as a separate bone; the middle and 
superior turbinates are part of the ethmoid bone (Măru, Rusu, and Săndulescu 2015).  
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   Figure 6. Inferior Turbinate with Nasolacrimal Duct. Drawing of the anterior nasal cavity, including the inferior turbinates surrounding the inferior meatus and the nasolacrimal ducts that feed into the inferior meatus.   
The following sections will detail the histology, embryology (including growth and 
development), innervation, blood supply, and autonomic receptors of the inferior 
turbinates.  
Histology 
The lining of the nose has a mucosal epithelial layer on top of a submucosal layer. The 
mucosa consists of a protective pseudostratified columnar (respiratory) epithelium 
(Figure 7). Within this epithelium are mostly ciliated (and some non-ciliated) columnar 
cells, goblet cells, and basal cells. The cilia have a length of about 5 μm and protrude out 
into the nasal cavity, where they are able to mechanically move mucous particles. The 
goblet cells produce secretions that add to the mucous film that covers the epithelium. 
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Basal cells can differentiate if needed (Sahin-Yilmaz and Naclerio 2011). Mast cells, 
eosinophils, and lymphocytes from the immune system also reside in the mucosa (Jafek 
1983). The folded structure of the inferior turbinates can increase the mucosal surface 
area of the nasal cavity up to 200 cm² (Joseph D Brain et al. 1977).  
   Figure 7. Mucosal Epithelial Layer. A drawing of respiratory epithelium showing ciliated columnar cells, goblet cells, and basal cells.  
Immediately following the basement membrane of the epithelial mucosal layer is the 
submucosa (Figure 8). This layer contains glands, nerves, and blood vessels. The three 
most common types of glands in the submucosa, anterior serous glands, seromucous 
glands, and Bowman glands, produce the majority of the nasal secretions. Anterior serous 
glands are generally found close to the nasal vestibule (by the nostril) and assist in 
moisturizing the mucosa. Seromucous glands are found throughout the cavity but are 
most commonly located in the anterior section. They secrete either a serous or a mucous 
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fluid. Bowman glands are located in the olfactory region and aid in the sense of smell. 
Inflammatory mediators are also found in the submucosa, such as histamine, bradykinin, 
prostaglandins, and cytokines (Sahin-Yilmaz and Naclerio 2011).  
  Figure 8. Submucosal Layer. A drawing of the exterior layer of the inferior turbinate, featuring respiratory epithelium and a large submucosa with various glands and vasculature.   
Embryology 
The major development of the face occurs between the 4th and 8th weeks of gestation. The 
development includes contributions from the head ectoderm, which creates the face, oral 
cavity, and mucosal lining, and the neural crest mesenchyme, which assists in the 
formation of the initial cartilaginous framework that later ossifies into bone of the inferior 
turbinate (Platt, Devaiah, and Marple 2014). The neural crest mesenchyme is derived 
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from the neural crest and prechordal plate. The developing frontonasal area has 
mesenchyme from two origins of neural crest cells, the midbrain neural crest cells, which 
result in the lateral nasal process that includes the inferior turbinate, and the forebrain 
neural crest cells, which form the medial nasal processes (Som and Naidich 2013).  
The inferior turbinate arises from two origins, the maxilla and the lateral cartilaginous 
capsule. At 8 weeks, three soft tissue preturbinates can be identified within the nasal 
cavity, which is surrounded by a cartilaginous nasal capsule. By week 10, this capsule 
develops into two cartilaginous plates that invade the soft tissue of the inferior and 
middle turbinate (Bingham et al. 1991). By week 14, the maxilla expands and forms the 
lateral wall of the inferior meatus (Som and Naidich 2013). By 16 weeks, the inferior 
turbinates, as well as the middle and superior, are well shaped. By 18 weeks, inferior 
turbinate ossification of its cartilaginous precursor occurs. Development of the lateral 
nasal wall is generally complete by 24 weeks (Bingham et al. 1991).  
The maturation of the mucosal and submucosal surfaces follows a similar timeframe.  
Ciliated epithelium appears at week 9, as does vascularization. The glandular acini and 
the goblet cells start to develop around the 11th week. Mucosal and submucosal 
development continues and differentiation is also completed around the 24th week 
(Watelet and Van Cauwenberge 1999).  
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Innervation  
Nerves in the nasal cavity are considerably involved with the local regulation of airflow, 
blood flow, secretion from glands, and the sense of smell. Accordingly, the nasal cavity 
contains a complex neuronal system that includes sensory, parasympathetic, and 
sympathetic nerves (Sarin et al. 2006). This thesis will focus on the parasympathetic and 
sympathetic nervous systems within the nasal cavity. 
The parasympathetic neurons arise in the superior salivary nucleus of the midbrain and 
then journey with the neurons of cranial nerve seven, the facial nerve. At the geniculate 
ganglion in the temporal bone, these neurons separate and compose the greater superficial 
petrosal nerve. These neurons travel along the base of the anterior cranial fossa and the 
pterygomaxillary space and synapse in the sphenopalatine ganglion. Parasympathetic 
postganglionic neurons then enter the nose through the sphenopalatine foramina. From 
here, parasympathetic postganglionic fibers are distributed to the mucosa and submucosa 
by branches from the sphenopalatine ganglion (Sahin-Yilmaz and Naclerio 2011). 
Postganglionic fibers contain the expected acetylcholine as well as neuropeptides, such as 
vasoactive intestinal peptide and secretoneurin (Korsgren et al. 2005). Stimulation of 
these parasympathetic fibers results in glandular secretions and some vasodilatation of 
blood vessels (Borum 1979).  
The sympathetic neurons arise in the hypothalamus. These neurons exit the central 
nervous system in the cervical spine, synapse in the superior cervical chain ganglion 
(from this point on the fibers are considered postganglionic), and then journey with the 
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carotid plexus until the pterygoid canal, where they combine with the parasympathetic 
neurons from the facial nerve to create the vidian nerve. The sympathetic neurons do not 
synapse in the sphenopalatine ganglion, as the parasympathetic ones do, but go on to 
innervate the mucosa and submucosa (Sahin-Yilmaz and Naclerio 2011). Sympathetic 
fibers contain norepinephrine and Neuropeptide Y. Sympathetic effects occur when 
neurotransmitters stimulate adrenoceptors, which results in vasoconstriction, decreasing 
airway resistance (Baraniuk et al. 1990).  
Blood Supply 
The inferior turbinate receives blood mainly from branches of the external and internal 
carotid arteries, with some possible contributions from the facial artery (Figure 9). The 
external carotid branches into the internal maxillary, which branches into the terminal 
sphenopalatine artery. The sphenopalatine artery enters the nasal cavity through the 
sphenopalatine foramen on the posterior lateral inferior wall (Dawes and Prichard 1953). 
The internal carotid artery branches into the ophthalmic artery, which branches into the 
anterior ethmoidal artery. The anterior ethmoidal artery enters the nasal cavity through 
the orbit and the lamina papyracea. Branches of the anterior ethmoidal artery anastomose 
with branches of the sphenopalatine artery in the area of the inferior turbinate, giving the 
turbinate a robust blood supply (Sahin-Yilmaz and Naclerio 2011). Nutrient-rich blood 
reaches its destination through the smallest vessels of this area, the subepithelial, 
glandular, and periosteal capillaries. Nutrient-depleted blood then leaves the nasal cavity 
through veins that mainly follow adjacent to the arteries. The ethmoidal veins pass 
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through the cribriform plate and eventually reach the sagittal sinus. The sphenopalatine 
veins are continuous with the venous plexuses of the palate and nasopharynx and also 
pour into the infraorbital vein (Dawes and Prichard 1953). 
  Figure 9. Arteries of the Inferior Turbinate. Anastomoses between branches of the sphenopalatine and anterior ethmoidal (not labeled; top-left artery shown) arteries supply the inferior turbinate.   
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Autonomic Receptors  
Adrenergic and muscarinic receptors, belonging to the sympathetic and parasympathetic 
systems, respectively, are commonly found on the inferior turbinate and play a vital role 
in the innervation of the local submucosal glands and vasculature.  
Adrenergic receptors are G-protein coupled cell membrane receptors. They receive the 
sympathetic neurotransmitter norepinephrine and respond by activating second 
messengers or ion channels. Adrenergic subtypes include three α1 subtypes: α1A, α1B 
and α1D; three α2 subtypes: α2A, α2B and α2 C; and three β subtypes: β1, β2 and β3 
(Kirstein and Insel 2004).  Immunohistochemical analysis was carried out using anti-
human adrenergic subtype-specific protein antibodies (α1A-, α1D-, α2C- and β2-
adrenergic receptors). The immunostaining displayed that submucosal glands contain a 
high amount of α1D- and β2-adrenergic receptors while smooth muscle surrounding the 
vasculature contains a high amount of α1A- and α2C-adrenergic receptors (Shirasaki, 
Kanaizumi, and Himi 2016).  
Muscarinic receptors are also G-protein coupled cell membrane receptors. They receive 
the parasympathetic neurotransmitter acetylcholine and respond similarly to adrenergic 
receptors. Muscarinic subtypes include m1, m2, m3, m4, and m5. In an experiment 
similar to the one above, immunostaining revealed m1 and m2 receptors are commonly 
distributed on glands, arteries, veins, and epithelia. M3 receptors are extensively 
dispersed on glands, arteries, and veins. Receptors of type m4 were identified in arteries. 
M5 receptors were found sparingly on glands and arteries. M3 receptors appear to 
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dominate in number and are likely the most important muscarinic receptor to the 
physiology of the inferior turbinate (Nakaya, Yuasa, and Usui 2002).   
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NORMAL PHYSIOLOGICAL FUNCTION OF THE INFERIOR TURBINATE 
 The turbinates serve to warm, humidify, and filter inspired air, with the inferior turbinate 
being chief among the others in fulfilling these functions. To fully comprehend its normal 
physiological function, as well as the later discussed environmental changes and 
pathology, an understanding of nasal patency and the nasal cycle must be reached. These 
topics will be discussed first and will then be followed by airway resistance, secretion, 
and immunity. 
Nasal Patency 
Nasal patency is defined as being a measurement of the openness of the nose. However, it 
is not necessarily equivalent to airflow or its resistance, although patency does effect 
airflow and resistance. When used correctly, nasal patency should refer to a cross-
sectional area or volume of the nasal cavity (Malm 1997). Unlike most physiological 
domains, it has proved difficult to set normal values for nasal patency. This is due to wide 
variations in the nasal cycle, external environment, congestion, age, height, weight, race, 
sex, and of course, nasal shape and size (Moore and Eccles 2012).  
Nasal patency can be determined through methods of computed tomography, magnetic 
resonance imaging, volumetry (both the closed cavity method and intranasal balloons), 
rhinostereometry, and acoustic rhinometry. Some authors also include expiratory or 
inspiratory peak nasal flow to calculate patency, although this method more accurately 
measures airflow (Malm 1997). Currently, acoustic rhinometry is the newest and 
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arguably the most promising method because it can be done quickly and non-invasively. 
Sound waves are emitted into the cavity and measurement equipment analyzes the 
intensity and arrival time of the echo. Using this data, the known distances can be 
converted into useful cross-sectional area measurements for topographical maps of the 
nasal and nasopharyngeal airways, generating a better understanding of the openness of 
the nasal cavity (Melo et al. 2015).  
Nasal Cycle 
The nasal cycle refers to the asymmetrical, spontaneous changes in congestion or 
vasodilation and decongestion or vasoconstriction of nasal mucosal large veins. As the 
left inferior turbinate becomes more congested with blood, airflow through the left nasal 
cavity decreases. Meanwhile, the right inferior turbinate decongests and airflow increases 
through the right nasal cavity. Between 50 minutes and 4 hours, the congestion and 
decongestion reverse in at least 80 percent of the population and the cycle continues 
(Hasegawa and Kern 1977). A normal individual is generally unaware of the nasal cycle, 
since total nasal airflow remains constant (Sahin-Yilmaz and Naclerio 2011).  
While precise research is still lacking, the “pacemaker” that generates and controls the 
nasal cycle is believed to be located within the suprachiasmatic nucleus of the 
hypothalamus in the brain (Mirza, Kroger, and Doty 1997). From the hypothalamus, the 
cycle is believed to be controlled by the sympathetic nervous system through the 
previously mentioned sympathetic fiber pathway to the inferior turbinate because the 
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cycling can be terminated by a sympathetic cervical ganglion blockade (Rooker and 
Jackson 1969).  
Airway Resistance 
Airway resistance can be defined as “the opposition to flow caused by the forces of 
friction” (“Airway Resistance” 2016). Resistance within the nasal airway is responsible 
for more than 50 percent of total airway resistance. The nasal valve, of which the inferior 
turbinate makes up the lateral border while the septum makes up the medial border, is the 
area of the nose with the highest airway resistance. Air must flow through this valve in 
each direction (Bailey 1998).  
Resistance plays an important role in the normal physiology of respiration. During 
inspiration, the friction added by the inferior turbinate slows the laminar flow of air and 
allows it to spend more time in the nasal cavity, interacting with the warm epithelial 
mucosa as turbulent flow. These precious extra moments of interaction with the mucosa 
allow the air to be warmed, humidified, and filtered. It has been shown that air can be 
warmed up to 34 degrees Celsius and humidified up to 80 percent relative humidity 
before reaching the pharynx (Lindemann et al. 2004). Hence, a healthy nose can provide 
approximately 90 percent of the heat and moisture needed to prepare inspired air to 
alveolar conditions. The inferior turbinate by itself contributes to about 16 percent of 
conditioning, which is the largest contribution by any one structure in the airways. These 
nasal figures greatly outperform the capacities of the mouth, which is why it is better to 
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breathe thru the nose for proper conditioning and improved lung function (Naftali et al. 
2005).  
During expiration, nasal airway resistance is needed to keep air in the lungs for a certain 
period. Because a positive pressure difference exists between the lungs and the 
atmosphere, air wants to flow down its gradient: from the lungs, out through the nose, 
and into the atmosphere. Nasal resistance keeps air from exiting so easily. Hence, the 
nasal valve functions as a respiratory brake, allowing sufficient time for gas exchange 
within the alveoli in the lungs (Hairfield et al. 1987).  
As evident in the nasal cycle, the size of the turbinates is one of the major factors in 
determining nasal airway resistance. The larger the inferior turbinate, the more resistance, 
the less air flows through the nasal cavity. Since the cycle is controlled by the 
sympathetic nervous system, drugs that affect this system can be applied to create desired 
airflow effects. One example is an α-adrenergic receptor agonist drug that mimics 
sympathetic agents to increase airflow. They function by binding to adrenergic receptors, 
which starts a excitatory cascade that results in decreased volume of the nasal mucosa, 
which decreases resistance and increases airflow (Shirasaki, Kanaizumi, and Himi 2016). 
Other agonists would have similar effects, while antagonists could reverse the process. It 
is important to note that parasympathetic innervation can also affect the size of the 
turbinates, since all subtypes of parasympathetic muscarinic receptors are found on the 
arterioles and venules of the submucosa.   
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The size of the inferior turbinate, specifically its mucosa, can also be changed by other 
factors including exercise, emotions, hormones, and environment (Ohki et al. 1987). 
Many of these topic will be explored in a later section.  
Secretion 
Filtration is the other vital responsibility of the nose. Inspired air contains a high 
concentration of particles, which would end up in the alveoli of the lungs if they were not 
filtered. This can result in damage to these fragile structures. To keep particles out of the 
lungs, they are trapped in the watery mucous film covering the nasal epithelium. The 
film, or blanket, is 10 to 15 μm deep and is made up of glandular secretions from goblet 
cells and other submucosal glands. The blanket covers the entire nasal cavity, including 
the inferior turbinate (Wilson and Allansmith 1976). It is estimated that goblet cells and 
other submucosal glands produce between 0.1 to 0.3 mg/kg of mucus per day. Large 
particles (greater than 3 μm) are generally filtered in the nasal valve, while smaller 
particles (between 3 and .5 μm) are trapped by the mucosa (Sahin-Yilmaz and Naclerio 
2011). Because of its location as part of the nasal valve and its histological structure that 
includes the nasal mucosa, the inferior turbinate plays a role in filtering a large range of 
particles. After particles are trapped in the mucus, the epithelial cilia beat in a fixed 
direction to move the mucous blanket towards the nasopharynx and into the oropharynx, 
where they can be swallowed and then neutralized by acid within the stomach. In 
addition to filtration, the secreted mucus also helps to warm and humidify the air. The 
watery secretions tend to be warmer than the inspired air, since they come from the 
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interior of the body. As in humidification, the mouth does not filter as well as the nose, 
which also indicates the importance of nasal breathing versus oral breathing (Watelet and 
Van Cauwenberge 1999).  
The parasympathetic nervous system mainly controls glandular secretion in the nasal 
mucosa, especially in the inferior turbinate (Eccles and Wilson 1973). As previously 
mentioned, parasympathetic cholinergic receptors, specifically the muscarinic subtypes 
m1, m2, m3, and m5, are found on the glands of the inferior turbinate mucosa (Nakaya, 
Yuasa, and Usui 2002). Cholinergic agonist drugs such as methacholine result in 
hypersecretion (Brofeldt et al. 1986), while anticholinergic antagonist drugs including 
atropine and ipratropium decrease secretion (Borum, Larsen, and Mygind 1979).  
Immunity 
The nose also participates in providing defensive immunity to the body. In addition to the 
trapping and subsequent neutralization of dangerous particles, it is also a first line of 
defense against bacteria and viruses. Immunoglobulin A (IgA), an antibody known to 
play a vital role in mucous membranes throughout the body, is produced in the 
submucosa of the nasal cavity, including the inferior turbinate. IgA is the major 
immunoglobulin found in nasal secretions and it can bind dangerous pathogens from the 
air that have become trapped in the mucous blanket before they can penetrate into the 
nasal mucosa and effectively access the blood stream or lymph (Bellanti, Artenstein, and 
Buescher 1965).  
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Mast cells, eosinophils, and lymphocytes are also present in the mucosa to provide 
immunity (Jafek 1983). Specifically, T-helper cells, T-cytotoxic cells, B cells, Natural 
Killer cells, neutrophil granulocytes, eosinophil granulocytes, and macrophages have 
been located in the inferior turbinate. In patients with chronic sinusitis, T-helper cells, T-
cytotoxic cells, and B cells significantly increase in number compared to patients without 
sinusitis (Grevers et al. 2000). Additionally, lactoferrin, lyzozyme and kallikrein, 
antimicrobial enzymes capable of breaking down pathogens, are synthesized in the cells 
of the respiratory epithelium are found in glandular secretions of the submucosa (Watelet 
and Van Cauwenberge 1999). Other helpful antimicrobial agents found in the epithelial 
secretions include glycosaminoglycans, antioxidants and antibacterial substances (Jeffery 
1983).  
Although the parasympathetic system is generally activated for secretion, there is 
evidence that the sympathetic nervous system can be utilized as well. For example, it has 
been shown that sympathetic innervation by both types of adrenergic receptors is needed 
for the secretion of IgA from the nasal mucosa during acute stress (Jarillo-Luna et al. 
2015). This is made possible by the α1D- and β2-adrenergic receptors that are found on 
the submucosal glands.  
Sneezing may also be included in this category, since its purpose is to expel mucus-
trapped foreign particles or irritants from the nasal cavity. Sneezing is an autonomic 
response with both respiratory and nasal phases. An irritant is first presented within the 
nasal mucosa. Trigeminal nerve endings are activated and signals are sent afferently to 
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the brain, where the respiratory phase begins (Songu and Cingi 2009). While the sneezing 
control center has been found in the brainstem of the cat (Nonaka et al. 1990), its location 
has yet to be confirmed in humans (Seijo-Martínez et al. 2006). From this central area in 
the brain, efferent signals leave to activate abdominal, intercostal, and pharyngeal 
muscles, resulting in the sneezing mechanism to clear potentially immuno-compromising 
irritants from the nasal cavity (Brubaker 1919). It has also been hypothesized that the 
nasal phase, which results in nasal secretions that dilute and remove irritants in the nose 
to prevent it from entering the lungs is the true purpose of the sneeze (Burke 2012). 
These signals travel along the parasympathetic nerves of the sphenopalatine ganglion 
(Brubaker 1919). It is likely that both phases play a necessary role in the function of nasal 
immunity.  
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ENVIRONMENTAL PHYSIOLOGY OF THE INFERIOR TURBINATE 
Certain environmental situations result in necessary adaptations within the nasal cavity to 
maintain homeostasis. Such circumstances include an increase or decrease in temperature 
and/or humidity, exercise, sleep, taste sensation or gustatory rhinitis, and pressure on a 
specific body part such as the crutch phenomenon. These situations, and the autonomic 
contributions, will be explored below. Much of the research presented does not focus 
solely on the inferior turbinate, but on the nasal cavity as a whole. Still, with the 
importance of the inferior turbinate within the cavity clearly evident (as previously 
described above), it can be understood that it continues to play a large part in homeostasis 
due to its role in airway resistance, secretion, etc.   
Temperature  
In cold weather, there tends to be an increase in nasal secretions. When cold air is inhaled 
and comes in contact with the nasal mucosa, the glands secrete extra water and mucus. 
This extra addition to the mucous blanket is needed to assist in warming and humidifying 
the air for preparation of entry into the alveoli. The colder the air is, the greater quantity 
of water and mucus that need to be produced (Shmerling 2011). It has been shown that, 
when exposed to cold air, nasal airflow slightly increases on average (Pirilä, 
Kiukaanniemi, and Jokinen 2000), or may slightly decrease (Proctor, Andersen, and 
Lundqvist 1977). As such, it seems there is not much of a change in nasal resistance in 
cold weather. This finding marks an interesting insight into turbinate physiology. Cold 
weather should induce vasoconstriction of surface vasculature, as it does in other 
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locations, to keep heat in the body. This should result in shrinkage of the turbinate 
mucosa, since they would receive less blood. However, the need to warm the incoming 
cold air must take physiological precedence, as nasal resistance hardly changes, 
indicating conserved blood flow to the turbinates. It is important to note that some 
otolaryngologists believe cold air within the nose may increase blood flow. These 
physicians may rely on an irrigation technique using hot water to decrease blood flow 
during posterior nasal epistaxis, and this technique has proven to be as effective as more 
conventional methods (Schlegel-Wagner, Siekmann, and Linder 2006).  
Conversely, a hotter climate tends to decrease the need for nasal secretions. Since the air 
is already warm, secretion is not as relied upon as a method of heating (Shmerling 2011). 
Resistance decreases in warm air, since there is not as much need for air to stick around 
longer in the mucosa to heat up (Proctor, Andersen, and Lundqvist 1977).  
Humidity 
The perceived effects of humidity on the inferior turbinate are similar to those of 
temperature. The drier the air, the more need for secretion. The wetter, or more humid the 
air, the less a need for secretion exists (Shmerling 2011). However, it has been shown 
that there is no significant change in nasal mucus flow, or secretion, between 10 and 70 
percent relative humidity, if the temperature is kept constant at 23 degrees Celsius 
(Andersen, Lundqvist, and Proctor 1972). The difference in perception and experimental 
results may be due to the fact that cold air tends to be drier, so the increased secretion 
may be caused solely by the cold temperature. It is possible that experimental results 
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could become significant at more extreme relative humidity values, such as 0 or 90 to 100 
percent. The same study also revealed that there is no change in nasal airflow resistance 
between 10 and 70 percent relative humidity (Andersen, Lundqvist, and Proctor 1972). It 
can be assumed that the mucosal changes that do occur do so under the direction of the 
innervating autonomic nervous system. 
Exercise 
At rest, the nose is capable of taking in 20 to 30 liters of air per minute (Sahin-Yilmaz 
and Naclerio 2011). During exercise, metabolic use of oxygen by muscle and other 
organs increases. As such, an uptake in oxygen is required and respiration must increase. 
More air must flow thru the nasal cavity, and mouth-breathing, though not as efficient at 
conditioning inspired air, may also be required depending on the body’s primary need for 
oxygen. To accommodate this, the size of the turbinates decreases, allowing for a greater 
nasal cavity volume and decreased resistance. Nasal airflow resistance as measured by 
rhinomanometry decreases by approximately 70 percent during exercise (Sozansky and 
Houser 2014). The duration of exercise has also been shown to decrease resistance more 
than the intensity (Fonseca, Voegels, and Pinto 2006).  
The autonomic system controls the reduction in size of the inferior turbinate during 
exercise. Specifically, the sympathetic portion, which tends to control other “fight or 
flight” actions including as exercise, is responsible. Sympathetic fibers induce active 
vasoconstriction in the nasal mucosa (Fonseca et al. 2006). This is likely accomplished 
by activating α1A- and α2C-adrenergic receptors within the smooth muscle of mucosal 
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vasculature. This action would have a dual purpose in the body’s exercise physiology; not 
only does the decreased blood flow to the inferior turbinate result in decreased turbinate 
size and thus decreased resistance, but the blood is made available to transport oxygen to 
other parts of the body that require greater uptake during exercise.  
Exercise also impact the ability of the mucosa to condition. It has been shown that even 
at a moderate level of exertion in a comfortable environment, the air conditioning 
capacity of the nasal cavity was reduced by up to 11 percent (Naftali et al. 2005). This is 
likely due to the fact that, with the decreased resistance, inspired air is spending less time 
interacting with the warm and humid mucosa. As exercise intensity and duration 
maximize, the efficiency of the mucosa to condition would be expected to substantially 
decrease to a currently unknown level.  
While air may not be sufficiently conditioned during exercise, the autonomic system 
works tirelessly to ameliorate this anomaly by stimulating additional submucosal 
secretions, especially in cold weather. Mucus flow and volume both increase significantly 
during exercise in colder temperatures (Pirilä, Kiukaanniemi, and Jokinen 2000).  
Sleep 
During sleep, the metabolic demand for oxygen is suppressed. As such, respiration slows 
compared to normal basal levels. Breathing is also completely controlled by the 
autonomic system during sleep. Most humans tend to sleep in a recumbent position 
(Pevernagie, De Meyer, and Claeys 2005). In this position, nasal resistance increases. 
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This is likely due to gravitational effects that disrupt emptying of vessels in a supine 
position versus an upright position. Capacitance venules and veins in the mucosa fill and 
don’t drain easily, leading to a swollen turbinate (Cole and Haight 1986). Oddly enough, 
the supine position decreases the ability of the nasal mucosa to condition air. 
Experimentation has shown nasal mucosal temperatures to drop more significantly in a 
supine position compared to an upright position. The mechanism that explains this 
decrease is unknown, but theories have been presented that focus on a decrease in blood 
flow to the nasal mucosa because of a decreased pulse during sleep (Assanasen et al. 
2001). This would decrease the blood’s ability to warm the mucosa, limiting the warming 
interaction between the mucosa and the inspired air. Still, blood should access the 
mucosa easier in the supine position due to the decreased gravitational pull and turbinate 
filling compared to the upright position, although the decreased draining of capacitance 
vessels may result in backflow of blood into resistance vessels. Obviously, there is still 
work to be done in this area.  
In addition to a supine position, other typical sleep positions include left lateral and right 
lateral recumbent postures. It is evident that sleep position has a great effect on the nasal 
cycle. The average duration of the cycle when supine almost doubles during sleep, from a 
measured value of 91.1 minutes to 178 minutes. Its amplitude increases as well 
(Rohrmeier et al. 2014). A positional shift during sleep also tends to alter the cycle. 
Lateral recumbency results in an increase in nasal resistance on the inferior side and a 
decrease in nasal resistance on the superior side. The increase in nasal resistance one the 
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inferior side while lying laterally is even greater than that of a simple supine position 
(Hasegawa 1982). Interestingly, a reversal of congestion in one side of the inferior 
turbinates does not appear to cause one to alter his or her sleeping position (Rohrmeier et 
al. 2014).  
A major sleep pathology that affects millions around the world, sleep apnea, will be 
discussed later.  
Gustatory Rhinitis  
Individuals often find that eating spicy foods results in a runny nose. This strange 
physiological action is known as gustatory rhinitis. Gustatory rhinitis is characterized by 
watery rhinorrhea, or mucus, seeping out of one or both sides of the nasal cavity after 
ingestion of unusually hot and spicy foods (Jovancevic et al. 2010). Evidence has shown 
this to be an autonomic reflex; sensory nerves in the olfactory portion of the cavity are 
stimulated and travel to the brain, where efferent signals are sent parasympathetically to 
the nasal mucosa, which are received by muscarinic receptors and result in secretion from 
the turbinate. The first step of treatment is avoidance of stimulatory foods, but there are 
other options if this is not possible. Application of an intranasal anticholinergic agent, 
like atropine, blocks the muscarinic receptors on submucosal glands and stops over-
secretion (Raphael, Raphael, and Kaliner 1989). Similar applications include ipratropium 
bromide and intranasal capsaicin. If these treatments aren’t effective, a surgical technique 
called a vidian neurectomy can be used to interrupt the parasympathetic supply to the 
nasal cavity (Georgalas and Jovancevic 2012). This technique is morbid and can lead to 
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chronic nasal and eye dryness, so it is generally performed as a technique of last resort 
(Jovancevic et al. 2010). 
Crutch Phenomenon 
Pressure applied to some body surfaces including the shoulders, arms, axilla, thorax, and 
pelvis can alter the nasal cycle (Haight and Cole 1984). An example of this, known as the 
“crutch phenomenon,” was first studied in 1970, although the idea has been around for 
much longer; yogis in India used it to correct left or right nasal airflow (S. Kuvalayanada 
and S. L. Vinekar 1963). When a crutch is placed under the arm of a sitting patient, the 
nasal cycle shifts so that the ipsilateral turbinate congests, increasing nasal resistance, 
while the contralateral side decongests, decreasing resistance. It is generally believed that 
autonomic reflexes near the shoulder or arm result in this ipsilateral congestion. There are 
two possible mechanisms that have been presented. First, pressuring the brachial plexus 
of this region may initiate a reflex that ascends to the brain, from which efferent impulses 
descent to the nasal mucosa of the turbinate by way of parasympathetic fibers, resulting 
in vasodilation. Second, the walls of the brachial and axillary arteries of this region may 
contain sympathetic nerve fibers that are irritated by the crutch. This could result in 
signals traveling antidromically to the superior cervical ganglion and then being sent 
efferently to the nasal mucosa, vasodilating its vasculature (Rao and Potdar 1970). A 
more recent study believes the second option, innervation by the sympathetic system, to 
be more likely (Davies and Eccles 1985).   
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PATHOLOGY OF THE INFERIOR TURBINATE 
Many pathological issues can arise within the inferior turbinate. Such issues include 
structural abnormalities such as concha bullosa, infectious diseases including tuberculosis 
and more, both allergic and non-allergic rhinitis, sleep apnea, and empty nose syndrome. 
These problems will be discussed here. In addition, inferior turbinate pharmacology and 
drug effects on the autonomic system will be detailed. 
Structural Abnormalities 
The most common structural abnormality found in the inferior turbinate is hypertrophy of 
the mucosa. A hypertrophied inferior turbinate (Figure 10) can be unilateral or bilateral, 
which may create asymmetric nasal cavities. This often results in partial or total 
obstruction of the nasal airways. Symptoms can include an inability to breathe through 
the nose, nasal congestion, mid-facial pain or pressure, and rhinorrhea. Allergies may 
contribute to the hypertrophy. Medical reduction through medication or surgery is often 
required to relieve congestion and facilitate nasal breathing and will be discussed in detail 
later (Hernandez 2016).   
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 Figure 10. Stages of Turbinate Hypertrophy. Hypertrophy of the inferior turbinate can increase until it obstructs the nasal cavity, severely limiting the flow of air.  
A rarer structural abnormality of the inferior turbinate is turbinate pneumatization, also 
known as concha bullosa (Figure 11). A pneumatization is an air-filled cavity or pocket 
within the turbinate. This is more common in the middle and superior turbinates, but 
cases have also been seen in the inferior turbinate. Concha bullosa is likely due to an 
embryological error. Like hypertrophy, it may also result in enlargement that becomes 
obstructive, and may require surgical reduction (Pittore, Al Safi, and Jarvis 2011).  
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 Figure 11. Concha Bullosa. Concha bullosa within the inferior turbinate are marked by arrows.  
Infectious Disease  
Infectious diseases that affect the nasal cavity include, but are not limited to, tuberculosis, 
rhinosporidiosis, rhinoscleroma, leprosy, syphilis, histoplasmosis, leishmaniasis, and 
sarcoidosis (Zargari and Elpern 2009). A few of the more prominent diseases that 
especially disrupt the inferior turbinate will be explored here.  
Tuberculosis is caused by a bacterium called mycobacterium tuberculosis. While it 
mainly affects the lungs, it can also invade the interior of the nose, especially the anterior 
part of the inferior turbinate and the nasal septum. It results in secretion from the mucosa, 
pain, and even possible perforation of the nasal septum (Zargari and Elpern 2009). 
Treatment for tuberculosis involves a variety of antibiotics (CDC 2016).  
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Rhinosporidiosis is a fungal disease caused by Rhinosporidium seeberi, which mainly 
affects the nasopharynx but can be present in other parts of the body. Fungal spores 
breathed in through the nose result in a reddish-pink mass on the nasal mucosa of the 
inferior turbinate. Surgery is usually required for removal (Aquino et al. 2016).  
Rhinoscleroma is a bacterial disease caused by Klebsiella rhinoscleromatis. It localizes in 
the upper airways, especially in the nasal mucosa of the inferior turbinate, after being 
inhaled through infected droplets (Shoeib 2010). Rhinoscleroma results in hypertrophy of 
the turbinate and has even been seen to infiltrate the tissue completely, separating the 
inferior turbinate from the lateral wall of the nasal cavity (Yassin, Badrawy, and Mokhtar 
1971). Antibiotics and surgical reduction are recommended (Mukara et al. 2013).  
Rhinitis 
Rhinitis is generally described as an irritation of the nasal mucosa that often results in 
swelling, congestion, and a runny nose. There are two categories of rhinitis, allergic 
rhinitis and non-allergic rhinitis. Allergic rhinitis is due to an overreaction of the immune 
system following the introduction of an allergen into the mucosa. The allergen is most 
often pollen carried in the air. Common treatments include avoidance, nasal steroids, 
antihistamines, and allergy shots. Non-allergic rhinitis is not a result of an over-active 
immune system. Instead, it can develop from exposure to odors, pollution, changes in the 
weather, or overuse of nasal decongestants. In addition, non-allergic rhinitis symptoms 
can be caused by medications, including blood pressure medicines, oral contraceptives, or 
medications used for erectile dysfunction. Nasal sprays including corticosteroids, 
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antihistamine, and Ipratropium are commonly used to treat non-allergic symptoms. 
Surgery may also be required (“Rhinitis” 2016).  
Research has shown that, within the inferior turbinate, nerve fibers in patients with 
allergic rhinitis were significantly increased within the epithelium, subepithelium, and 
glandular and vascular regions of the submucosa. A neurotransmitter for sympathetic 
nerve fibers, neuropeptide tyrosine, was also found in higher amounts in subepithelium 
and submucosal regions. Neuropeptide tyrosine is generally involved in vasoconstriction 
and decongestion of the mucosa (O’Hanlon et al. 2007). This increased concentration 
may indicate the need for excess innervation to alleviate the common allergic rhinitis 
symptom of congestion. It also provides a clear example of the importance of the 
autonomic system in the regulation of pathologic homeostasis within the inferior 
turbinate.  
Sleep Apnea  
Sleep apnea is a common chronic disorder in which the patient pauses in breathing for a 
few seconds up to minutes during sleep. It can happen over 30 times an hour and is 
obviously very disruptive to the sleep cycle, leading to daytime drowsiness. Obstructive 
sleep apnea is the most common type and results in the airway collapsing or being 
blocked during sleep, causing breathing to pause. In most cases, this is more due to a 
narrowing of the throat than the nasal cavity. Large tonsils, redundant pharyngeal tissue 
in overweight individuals, and over-relaxation of throat muscles are often to blame 
(“What Is Sleep Apnea?” 2012). Still, is it believed that the nose plays a role in sleep 
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apnea (Valipour 2014). This is due to nasal obstruction, including enlarged inferior 
turbinates, that would result in increased nasal resistance.  
Currently, clinical guidelines for the evaluation, management, and long-term care of 
obstructive sleep apnea in adults focuses on mainly pharyngeal procedures to eliminate 
obstructive sleep apnea. A few nasal surgical procedures, including inferior turbinate 
reduction, are discussed. However, the current belief is that such surgeries are rarely 
curative for obstructive sleep apnea, although they can improve clinical outcomes such as 
mortality, cardiovascular risk, function, quality of life, and symptoms (Epstein et al. 
2009). Some nasal surgeries may help patients manage their sleep apnea. One such 
surgery involves improving compliance with Continuous Positive Airway Pressure, 
which is the first line treatment for obstructive sleep apnea. A combination of septoplasty 
and inferior turbinoplasty have been shown to improve Continuous Positive Airway 
Pressure in patients with sleep apnea and nasal obstruction (Poirier, George, and 
Rotenberg 2014). A second compound nasal surgery consisting of septoplasty, 
submucosal inferior turbinectomy, and posterior nasal neurectomy significantly improved 
(but did not cure) obstructive sleep apnea without any pharyngeal procedures. Such 
procedures should be considered if high nasal resistance is present in sleep apnea patients 
(Hisamatsu, Kudo, and Makiyama 2015).  
Empty Nose Syndrome  
Empty nose syndrome is considered a rare iatrogenic complication of turbinate reduction 
surgery, mostly commonly following reduction of the inferior turbinate. Interestingly, it 
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tends to manifest itself years later. Symptoms include nasal obstruction (despite a lack of 
tissue that would be more likely to result in less obstruction and less nasal resistance), 
mucosal dryness and crusting, and a constant feeling of dyspnea. It is theorized that 
empty nose syndrome is caused by alterations to the local environment, lack of mucosal 
cooling, and derangement of neurosensory mechanisms (Kuan, Suh, and Wang 2015). 
The disruption of neurosensory mechanisms is especially harsh for patients, as it leads 
them to feel as though they are not able to respire sufficiently; a lack of sensitivity in the 
nose results in a persistent sensation of shortness of breath. Unfortunately, these 
symptoms can lead to anxiety and depression, including suicidal thoughts (“Empty Nose 
Syndrome” 2016). Medical and surgical therapies are available, including turbinate 
reconstruction using implants. These implants appear to be safe and quite effective, 
decreasing empty nose symptoms significantly (Houser 2007). Still, prevention of empty 
nose syndrome should be a focus of otolaryngologists. A surgeon can always remove 
more tissue if necessary and should err on the side of caution to avoid over-resection 
complications. It is important to note, however, that some physicians question whether 
symptoms of empty nose syndrome are actually caused by a lack of turbinate tissue (Das, 
Patel, and Poetker 2016). 
Pharmacology  
Multiple medical therapies to correct inferior turbinate dysfunction by influencing the 
autonomic system are available. Decongestants that generally reduce turbinate size and 
nasal resistance by vasoconstriction include oxymetazoline, pseudoephedrine, and 
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phenylephrine. Cocaine is also known to be a powerful and highly regulated 
decongestant. Table 1 summarizes medications and their effect on inferior turbinate 
function.  
Oxymetazoline, commonly marketed under the brand name Afrin, is a full α1 receptor 
agonist and a partial α2 receptor agonist. When oxymetazoline binds the alpha receptors 
found on the inferior turbinate vasculature, vasoconstriction occurs, the turbinate 
decongests, and nasal resistance decreases (Gómez-Hervás et al. 2015). Oxymetazoline 
has been shown to be arguably the strongest decongestant, achieving the most rapid 
onset, longest duration of action, and greatest improvement in airway patency when 
compared with pseudoephedrine, the next strongest decongestant (Connell and 
Linzmayer 1987).  
Pseudoephedrine, commonly marketed under the brand name Sudafed, is an indirect α 
agonist. It induces the vascular smooth muscle in the turbinate mucosa to vasoconstrict 
by releasing stored norepinephrine from sympathetic fibers within the vascular smooth 
muscle (Wang, Kao, and Chu 2006). This is the mechanism leading to inferior turbinate 
decongestion, and is quite effective. Because pseudoephedrine can be converted into a 
dangerous methamphetamine drug, the U.S. Senate passed a bill that restricts its sale 
(“What’s the Difference between Pseudoephedrine and Phenylephrine?” 2016).  
Phenylephrine, commonly marketed under the brand name Sudafed PE, is another α 
agonist decongestant. Unfortunately, it does not seem to be more effective than a placebo 
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when taken orally, perhaps because it is not absorbed well (Horak et al. 2009). As such, it 
is also marketed as a local nasal spray, which is likely to be significantly more effective 
than the oral pill.  
Other medications to manage inferior turbinate dysfunction exist. Oral or intranasal spray 
antihistamines block histamine effects, such vasodilation, at H1 receptor sites and are 
especially useful when combined with decongestants. Intranasal corticosteroid sprays 
improve rhinitis and also contain general anti-inflammatory properties, reducing turbinate 
size. While the exact mode of action of intranasal corticosteroid sprays is unknown, it is 
believed that the steroid penetrates and acts locally in the nasal mucosa. It may also target 
inflammatory cells and their chemical mediators such as epithelial cells, lymphocytes, 
basophils, mast cells, and Langerhans cells (Mygind et al. 2001). A leukotriene receptor 
antagonist, montelukast, is also used to alleviate rhinitis and has shown to reverse nasal 
congestion (Archer 2016).  
Cocaine is a powerful drug that is often illicitly made into a powder form and snorted 
through the nose. In addition to a host of other effects, it functions as a local 
vasoconstrictor and decongestant within the nasal cavity and is used in surgical practices. 
Long-term abuse, however, can lead to inferior turbinate hypertrophy (Hamilton 2016). 
Yet in some individuals, long-term use has resulted in erosion of the turbinates and nasal 
septum, eventually causing complete collapse of the nose (Villa 1999).  
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Drugs not intended to affect the nose may still have side effects there. Alpha blockers 
such as silodosin, a treatment for benign prostatic hyperplasia, can vasodilate the vessels 
of the inferior turbinate, congesting the nose (Fonseca and Da Silva 2015). Theoretically, 
beta blockers such as β2-adrenergic receptor antagonists could decrease submucosal 
secretions, limiting the effectiveness of the turbinate to condition inhaled air. In addition, 
some non-specific beta blockers can have alpha blocker activity that may lead to nasal 
congestion (Rosendorff 1993). Sildenafil, commonly marketed as Viagra, increases the 
effect of the vasodilator nitric oxide, and has been shown to result in nasal congestion 
(Kiroglu et al. 2006). Xanax, an anticholinergic medication for depression, carries a less 
common but known side effect of nasal congestion (“Xanax Side Effects in Detail” 
2016). Xanax likely causes vasodilation through at least the m3 receptor in submucosal 
vasculature.  
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Table 1. Medications That Affect Turbinate Function 
Medications Effect 
Oxymetazoline (Afrin) Decongestant  
Pseudoephedrine (Sudafed) Decongestant 
Phenylephrine (Sudafed PE) Decongestant 
Cocaine Decongestant 
Loratadine (Claritin) Antihistamine 
Loratadine + Pseudoephedrine (Claritin D) Antihistamine, decongestant  
Silodosin (Rapaflo) Congestant 
Sildenafil (Viagra) Congestant  
Xanax Congestant 
Montelukast Anti-inflammatory, decongestant 
Corticosteroid Sprays (Nasacort, Rhinocort) Decongestant, decrease mucus secretion 
Antihistamine Sprays Antihistamine  
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REDUCTION OF THE INFERIOR TURBINATE 
Inferior turbinate hypertrophy that results in nasal obstruction can occasionally be 
managed by medications such as intranasal steroidal sprays and typical allergy drugs. 
Unfortunately, this is often not sufficient. Depending on the individual’s nasal anatomy, 
office-based or maximal operating room surgery may be recommended. Medical and 
surgical turbinate reductions will be detailed here, as well as their autonomic impact.  
Medical Reduction  
Although transient reduction in turbinate size can be achieved with many of the 
medications outlined in the pharmacology section, durable reduction and symptom 
improvement from medical therapy is generally achievable only with topical sprays that 
target autonomic controls. Nasal corticosteroid sprays such as Nasacort or Rhinocort 
reduce general swelling due to congestion and mucus secretion from the turbinates. 
Topical nasal antihistamine sprays are also effective at reducing nasal congestion. 
Prolonged use of these sprays does not appear to cause ineffectiveness. Other previously 
mentioned decongestants such as Afrin (which is a spray) and Sudafed also reduce the 
size of the inferior turbinate (Archer 2016). A typical allergy medication such as Claritin-
D, a combination of the antihistamine loratadine and decongestant pseudoephedrine, 
reduces turbinate hypertrophy by relieving nasal congestion (McFadden et al. 2000). 
Unfortunately, prolonged use of decongestants may reduce effectiveness (Archer 2016).  
Surgical Reduction   
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Surgical therapy may be necessary for patients in whom medical management of inferior 
turbinate hypertrophy is no longer responsive. Because of the important function of the 
turbinates in respiration, conditioning, and immunity, and the possible side effect of 
empty nose syndrome, special care must be taken to avoid excessive resection. The 
surgeon should focus on addressing the obstructive problem while maintaining function 
of the autonomic features.  
Minimal surgical reduction of the inferior turbinate may be done in the office of an 
otolaryngologist. Office-based therapies include radiofrequency and electrocautery. The 
first technique uses radiofrequency to place lesions within the submucosa of the 
turbinate, which reduces tissue volume while minimizing impact to other surrounding 
structures. It has proven to be a safe and effective therapy to reduce obstruction without 
actually altering the outer mucosa (Coste et al. 2001). Ciliary motility may take up to 3 
months to fully recover, although this doesn’t significantly affect function (Rosato et al. 
2016). Saccharin transit time, a method of measuring turbinate function by calculating 
mucociliary flow rate, was not significantly altered (Rhee et al. 2001). Coblation is a 
popular subtype of radiofrequency therapy that can be used to remove additional tissue. A 
small applicator is threaded under the mucosa through a small incision, and then directs 
coblation waves that slowly melt the bone and soft tissue (Isaac Namdar 2016). It is also 
generally effective, though rare individuals may have vascular damage that leads to 
epithelial shedding and hinders function (Berger et al. 2008). While radiofrequency 
therapy generally has minimal post-op complications and pain, its efficacy tends to 
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decrease after 3 years (Passali et al. 2016). Electrocautery is similar to radiofrequency, 
but uses electrical current instead. It has been shown to be just as safe and effective as 
radiofrequency, with the same limited complications (Uluyol et al. 2016). With each of 
these techniques proven safe and effective, the choice is left to the discretion of the 
surgeon.  
Maximal surgical reduction is generally performed in the operating room of a hospital. 
The type of surgery is chosen after determining whether the cause of inferior turbinate 
hypertrophy is soft tissue in nature, bony, or a combination of both. If excess soft tissue 
in the cause, a submucosal resection is often performed. The surgeon removes portions of 
the submucosa layer in order to shrink the overall volume of tissue. By removing portions 
of the submucosa only, receptors on the external layer of the mucosa are not affected 
(Bhandarkar and Smith 2010). The recent use of a microdebrider tool in this surgery, 
which permits continuous suctioning of blood from the area while quickly removing the 
tissue, has made this surgery even more effective and popular (Brunworth, Holmes, and 
Sindwani 2013). Despite the expected loss of turbinate function because of the vital role 
of the submucosa, it appears that mucus and IgA secretion are eventually restored to 
functional levels (Leong and Eccles 2010). If the cause of hypertrophy is bony or a 
combination of bony and soft tissue, partial turbinectomy is usually performed. Portions 
of the bone and/or submucosa may be removed during this surgery. Complications are 
minimal, but partial turbinectomy may negatively impact intranasal air heating, although 
it does not seem to affect humidification (Tsakiropoulou et al. 2015). Still, the relief of 
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nasal obstruction would likely outweigh these considerations. Full turbinectomy was a 
popular choice of surgeons until empty nose syndrome was discovered. Now, it has fallen 
out of favor due to the high rate of complications (Brunworth, Holmes, and Sindwani 
2013). Again, with most of these techniques proven safe and effective, the choice of 
surgery is left to the otolaryngologist. A study comparing radiofrequency therapy, 
submucosal resection with the microdebrider, and partial resection found no significant 
differences in major complications, patient satisfaction, improvement of nasal patency, 
and recurrence of nasal obstruction (Arganbright et al. 2015). The anatomical needs of 
the patient and comfortability level of the surgeon would likely be the key determinants 
when planning a course of action.  
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CONCLUSION 
 The inferior turbinates perform a highly valuable role in respiration and immunity. Their 
anatomy and histology allow air entering the nose to be warmed, humidified, and filtered 
before moving on to the lungs for optimal oxygen extraction. Additionally, size of the 
inferior turbinate due to blood flow drives nasal patency as mandated by the nasal cycle. 
The autonomic nervous system regulates these activities. Without the autonomic inferior 
turbinate, air would not be as well conditioned, breathing would be more difficult, and 
one would contract illnesses more readily.  
The inferior turbinate contains sympathetic adrenergic receptors within the glands and 
vasculature of the submucosa. Parasympathetic muscarinic receptors are found within the 
glands and vasculature of the submucosa, as well as on the epithelia of the inferior 
turbinate. Autonomic innervation that controls vasoconstriction and vasodilation of the 
vasculature in the submucosa administers the nasal cycle. As vessels enlarge and more 
blood is present in the inferior turbinate, nasal patency decreases and nasal resistance 
increases. As vessels constrict, a reversal takes place. The blood flow also contributes to 
the warming and humidifying capacity of the turbinate. The autonomic system also 
controls secretion rates, which add to the humidification and immunological functions. 
Many medications used to alleviate inferior turbinate dysfunction operate by interacting 
with autonomic fibers and receptors. While surgery to reduce inferior turbinate 
hypertrophy has not been shown to significantly alter function despite often removing 
vital tissue, this may be due to the fact that surgeons aim to only remove the extra tissue 
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that is initially present. The remaining tissue, when healed, is able to resume normal 
function.   
The inferior turbinate is composed of its own bone, is enclosed by specific soft tissue that 
contains parasympathetic and sympathetic receptors that receive innervation from the 
autonomic nervous system, and functions according to the input from those autonomic 
fibers. As such, it should be considered an autonomic organ.  
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FUTURE DIRECTIONS 
While much of the inferior turbinate and its autonomic properties have been thoroughly 
researched, potential topics still exist. A considerable amount of work needs to be done in 
the realm of surgery and its impact on the autonomic system. While some functional 
effects of various surgeries are somewhat known, additional research focusing on the 
surgical disruption of autonomic fibers and neurotransmitters is needed. It would also be 
pertinent to research whether autonomics lose control for some time following 
turbinoplasty and turbinectomy surgeries, and if that control is regained, or whether the 
remaining tissue is truly sufficient for function and never loses autonomic control.  
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